Form 4: Bed Bath & Beyond Director Debra Perelman Trades Shares
Insider Transaction Report
Debra Perelman, a Director at Bed Bath & Beyond, Inc., reported transactions involving restricted stock units and warrants.
Summary
- Director Debra Golding Perelman reported transactions on May 15, 2026, related to Bed Bath & Beyond, Inc. (BBBY).
- The transactions involved the vesting and delivery of 26,873 restricted stock units (RSUs) and the acquisition of 530 common stock warrants.
- Perelman also holds 35,181 RSUs that are scheduled to vest on May 14, 2027.
- The warrants, issued on October 7, 2025, allow the purchase of one share of common stock at an exercise price of $15.50 per warrant.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions (vesting of RSUs and acquisition of warrants) without providing company performance data or strategic updates.
Positives
- Vesting of 26,873 restricted stock units indicates continued compensation and potential value realization for the director.
- Acquisition of 530 common stock warrants provides potential upside if the stock price exceeds the exercise price of $15.50.
Negatives
- The filing does not explicitly detail any negative financial performance or operational challenges for the company.
Risks
- The value of the warrants is contingent on the stock price exceeding the $15.50 exercise price by October 7, 2026.
- The 35,181 RSUs scheduled to vest in May 2027 are subject to continued employment and company performance.
Future Outlook
The filing does not contain forward-looking statements or guidance from the company. The future outlook for the reported securities depends on the company's stock performance and the exercise of warrants.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently reflect company performance. The focus here is on the individual director's holdings and transactions within the retail sector.
Stakeholder Impact
- Shareholders: The transactions do not directly impact current share price but reflect insider confidence or compensation structure.
- Employees: The vesting of RSUs is part of the executive compensation plan, potentially influencing morale and retention.
- Management: Reflects the compensation and equity holdings of a key director.
Next Steps
- Debra Perelman may exercise the stock warrants if the stock price is favorable.
- The remaining 35,181 restricted stock units are scheduled to vest on May 14, 2027.
Key Dates
| Date | Description |
|---|---|
| 10/07/2025 | Date of original issuance of common stock warrants. |
| 05/14/2026 | Earliest transaction date reported; also the vesting date for 35,181 restricted stock units scheduled for 2027. |
| 05/15/2026 | Date of transaction for vesting of 26,873 restricted stock units. |
| 10/07/2026 | Expiration date for common stock warrants. |
| 05/14/2027 | Vesting date for 35,181 restricted stock units. |
Keywords
Bed Bath & Beyond, BBBY, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Warrants, Director Transactions, Securities Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.